Navigation Links
Safe Production of High-Titer Retrovirus

litates infection of the target cell by direct interaction with cell type-specific receptors; thus the host range of the virus is dictated not by the DNA vector but by the choice of the env gene used to construct the packaging cell.

The packaging cell line is transfected with the vector DNA and, at this point, either stable viral producer cell lines may be selected (providing the vector has an appropriate selectable marker) or mRNAs that are transiently transcribed from the vector are encapsidated and bud off into the cell supernatant. These supernatants are collected and used to infect target cells. Upon infection of the target cell, the viral RNA molecule is reverse transcribed by RT (which is present in the virion particle), and the cDNA of the gene of interestflanked by the LTRsis integrated into the host DNA. Because the vector itself carries none of the viral proteins, once a target cell is infected, the LTR expression cassette is incapable of proceeding through another round of virus production.

Due to recent advances in transfection technology high-titer viral supernatants can be produced following transient cotransfection of the viral vector together with expression vectors encoding the gag, pol, and env genes (Figure 1).3,4 This obviates the need for the production and maintenance of stable packaging cell lines.

Vector Description

Fig.2

The general structure of the packaging vectors is diagrammed in Figure 2. The vectors were designed with four aims in mind:

  • High Titer: MMLV gag-pol fusion protein and each of the envelope proteins are expressed at sufficiently high levels to allow the production of viral supernatants with titers greater than or equal to 107 cfu/ml following transient transfection.

  • '"/>


Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. A New C-Terminal GST Vector for Protein Production in S. pombe
2. Production of Full-Length, Biologically Active MEK1WT and MEK1CA
3. Yeast Protein Production System Features High Yields and One-Step Purification
4. Production of Hybridomas by Electrofusion
5. Production of Hybridomas by Electroporation
6. High Yield Protein Production from Pichia pastoris Yeast: A Protocol for Benchtop Fermentation
7. Gram Quantities of MAb Produced with Simple Bioreactor in Serum-Free Perfusion Culture Replacing Ascitic Fluid Production
8. High-Titer Retroviral Vectors for Gene Delivery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Safe Production High Titer Retrovirus

Breaking Biology News(10 mins):White, but not pure 2White, but not pure 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6The Lupus Foundation of America Applauds New Legislation that Caps Out of Pocket Drug Costs 53992 1The Lupus Foundation of America Applauds New Legislation that Caps Out of Pocket Drug Costs 53992 2Duane Reade Holdings Inc Announces Closing of Offering of 24300 Million of 11 75 25 Senior Secured Notes Due 2015 53986 1Duane Reade Holdings Inc Announces Closing of Offering of 24300 Million of 11 75 25 Senior Secured Notes Due 2015 53986 2Duane Reade Holdings Inc Announces Closing of Offering of 24300 Million of 11 75 25 Senior Secured Notes Due 2015 53986 3Duane Reade Holdings Inc Announces Closing of Offering of 24300 Million of 11 75 25 Senior Secured Notes Due 2015 53986 4Duane Reade Holdings Inc Announces Closing of Offering of 24300 Million of 11 75 25 Senior Secured Notes Due 2015 53986 5Duane Reade Holdings Inc Announces Closing of Offering of 24300 Million of 11 75 25 Senior Secured Notes Due 2015 53986 6WebMD to Present at the Canaccord Adams 29th Annual Global Growth Conference 53982 1